LOX and breast cancer: Moreover, the inhibition of LOX, which is induced by HIF-1α in hypoxic breast cancer cells at primary tumours by shRNA, was also effective at preventing the CD11b+ BMDC recruitment, pre-metastatic niche formation and metastatic growth of MDA-MB-231 breast cancer cells at lungs in a mouse model [257].